Hainan Shuangcheng Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of chemically synthesized peptide drugs and active pharmaceutical ingredients. It provides Thymalfasin for injection, which is used in the treatment of chronic hepatitis B, as well as used as a vaccine for patients with immune system functions suppressed; and Levocarnitine for injection to treat carnitine deficiency induced complications. The company also offers Clindamycin Hydrochloride for injection for amygdalitis, suppurative otitis media, and nasosinusitis; acute bronchitis, acute episode of chronic bronchitis, pneumonia, lung abscess, and bronchiectasia concurrent infection; skin and soft tissue infections; urinary system infection, acute urethritis, acute pyelonephritis, and prostatitis; and osteomyelitis, septicemia, peritonitis, and oral infection. In addition, it provides Thymopentin for injection to treat chronic hepatitis B; various primary or secondary T cell immunodeficiency diseases, such as children innate immunodeficiency disease; autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, etc.; various diseases with impaired cell immunity functions; and supplementary treatment of rumor diseases. Further, the company offers Famotidine for injection for patients with peptic ulcer hemorrhage; and intercurrent acute gastric mucosal lesion under stress condition, and gastrointestinal bleeding that is caused by nonsteroidal anti-inflammatory drugs. Additionally, it provides Somatostatin for injection for treating acute haemorrhage from oesophageal varices; acute haemorrhage from gastric or duodenal ulcers, or accompanying acute erosive or haemorrhagic gastritis; pancreas, gallbladder, and intestinal fistula; prophylaxis and postoperative; and diabetic ketoacidosis. The company was founded in 2000 and is based in Haikou, the People’s Republic of China.
hainan shuangcheng pharmac-a
16 Xingguo Road
Phone: 86 898 6865 3716
Fax: 86 898 6865 2226www.shuangchengmed.com
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for 002693.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact HAINAN SHUANGCHENG PHARMAC-A, please visit www.shuangchengmed.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.